Archive - April 2021
Opdivo improves survival in oesophageal cancer
Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
AZ showcases data for next-generation PARP inhibitor AZD5305
Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
Sanofi pays $160m upfront to acquire Tidal Therapeutics
Take the next step into CROY 2021
US approval for first AI device to help detect colon cancer